Episode 271: 270. Aprocitentan, How Well Does it Work for Resistant Hypertension? episode artwork

EPISODE · Apr 16, 2024 · 6 MIN

Episode 271: 270. Aprocitentan, How Well Does it Work for Resistant Hypertension?

from Questioning Medicine · host Questioning Medicine

730 Patients were randomized to receive daily oral aprocitentan or placebo, plus a fixed-dose combination of amlodipine, valsartan, and hydrochlorothiazide.After 4 weeks, mean change in office systolic BP was 15 mm Hg with aprocitentan and 11 mm Hg with placebo; this 4 mm difference was statistically significant.What is the cost? What is the long term effects? Why didn't they compare this to the standard of care spironolactone? https://www.hcplive.com/view/fda-approves-aprocitentan-tryvio-for-treatment-resistant-hypertensionhttps://www.thelancet.com/journals/lancet/article/PIIS0140-6736(22)02034-7/abstract

Episode metadata supplied by the publisher feed · Published Apr 16, 2024

Embed this episode

NOW PLAYING

Episode 271: 270. Aprocitentan, How Well Does it Work for Resistant Hypertension?

0:00 6:38

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Questioning Medicine?

This episode is 6 minutes long.

When was this Questioning Medicine episode published?

This episode was published on April 16, 2024.

Can I download this Questioning Medicine episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!